Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Oncotarget|March 5, 2016
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptidesPerry Tal, Shay Eizenberger, Elad Cohen, et al.International Journal of Cancer|December 24, 2016
Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitorsYoav Shetzer, Yael Napchan, Tom Kaufman, et al.Cell Death and Differentiation|May 14, 2024
Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblastsHimanshi Agarwal, Perry Tal, Naomi Goldfinger, et al.Oncotarget|June 14, 2019
Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptidesPerry Tal, Shay Eizenberger, Elad Cohen, et al.Plos One|May 1, 2013
Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon betaShalom Madar, Einav Harel, Ido Goldstein, et al.Haematologica|February 24, 2022
Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemiaAmos Tuval, Yardena Brilon, Hadas Azogy, et al.Pageof 1